Corporate Members

Nanomicro

Detaibio

Joinn Biologics

Xtalpi

Mabplex

Transcenta

Biocytogen

BGI

BGI Americas, the US subsidiary of BGI Genomics, is the leading provider of genomics and proteomics services. We operate in three business areas: next-generation sequencing, mass spectrometry, and IVD. Serving customers in genetics research, pharmaceutical R&D, and disease diagnostics, we are committed to advancing technologies and applications to benefit the mankind.

BGI Americas是华大基因旗下美国子公司，是领先的基因组学和蛋白质组学服务供应商。我们致力于高通量测序、质谱分析和体外诊断三个业务领域，服务于基因组学研究、医药研发和疾病诊断领域的客户。我们始终坚持推动科技成果的转化和应用，实现基因科技造福人类的目标。

GenScript

Yurogen

Yurogen develops and markets single B cell-based monoclonal antibody (mAb) discovery technology -- SMabTM technology which expediates mAb discovery with greater diversity, better efficiency, and multiple hosts (include rabbit, llama and human). Since 2016, Yurogen has delivered >400 mAb CRO projects using SMabTM technology for research tools, diagnostic products, and therapeutic leads.

SinoBiological

Sino Biological is committed to providing high-quality recombinant protein and antibody reagents and to being a one-stop technical services shop for life science researchers around the world. All of our products are independently developed and produced. In addition, we offer pharmaceutical companies and biotechnology firms pre-clinical production technology services for hundreds of monoclonal antibody drug candidates.

mAbsolve

mAbsolve is committed to improving the safety and effectiveness of therapeutic antibodies and Fc fusion proteins

Shuimu Biosciences

ShuimuBio is an evolving cryo-EM & AI platform empowering faster drug discovery via harnessing structural insights of difficult-to-crystallize biological targets.

UMABS

Umabs antibody therapies database (UmabsDB) provides a comprehensive scope of the global antibody therapies to boost research in industrial and academic communities. Coverage of 8100+ antibody, 1600+ target, 2300+ organization, 2800+ disease, antibody sequence, patent and clinical trial etc.

康日百奥 （Bioworkshop）

DIMA Biotech Ltd （缔码）

Alpalifebio

夏尔巴 Altruist

Asymchem 凯莱英

Bon Opus

Gator Bio

集萃药康GemPharmatech

Genscript probio

皓阳 Healsun Biopharm

华安生物

Shanghai InnoStar Biotech

Kactus

Chengdu NB Biolab Co.,LYD

Nona Biosciences

NovoProtein

Purolite

Sanyou

AceMab 泰楚

WuXi Biologics

Yurogen

臻格生物

Protheragen

Kactus Biosystems

Kactus Biosystems is providing recombinant proteins and GMP grade enzymes for drug discovery, CGT and mRNA vaccine customers. We have our featured products with stringent QC testing and customer validations to solve unmet needs, e.g. full length transmembrane proteins like Claudin 18.2 and GPRC5D, VLP, CD3, MHC complex, GMP grade CAS9 and vaccina capping enzymes.

Biointron

Founded in 2012,Biointron is committed to provide high quality and economic recombinant protein/antibody reagents and to be most reliable CRO vendor for life science researchers and biopharma companies.We can offer high-throughput recombinant antibody production;Bispecific antibody production;VHH Library Generation;Antibody humanization;Hybridoma sequencing service.We strive to accelerate the development process of antibody drugs.

Lepu Biotech Co. , Ltd

Lepu Biopharma Co., Ltd. is an innovation-driven biopharmaceutical company focusing on oncology therapeutics with a strong China foundation and global vision. Our mission is to become a leading innovative company serving the unmet medical needs of cancer patients with first-in-class and best-in-class drugs. We strive to continuously develop a market differentiating pipeline by combining in-house research and development and strategic collaborations, strengthen in-house manufacturing, and commercialize our product candidates through dedicated sales and marketing forces in China as well as via partnerships internationally.

Adlai Nortype

Adlai Nortye is a global clinical-stage biopharmaceutical company that is developing differentiated, innovative immuno-oncology medicines. Adlai Nortye focuses on discovering and developing important new treatments for cancer with a mission to improve patient lives by identifying and developing differentiated innovative medicines that help people live better, live longer. Through close collaborations with global partners, Adlai Nortye have successfully positioned itself in the field of immuno-oncology and have several programs ongoing from early pre-clinical to phase III ready.

Sanyou Biopharmaceuticals Co., Ltd.

Sanyou Biopharmaceuticals Co., Ltd. is a leading high-throughput research and development company for innovative antibody drugs.
Sanyou Bio has established a fully functional laboratory in Shanghai Caohejing High-tech Park, with advanced facilities and equipment on a site of more than 3000 m2. Sanyou Bio has developed and validated more than 20 state-of-art antibody discovery platforms, such as “sub-Trillion Human Naïve Antibody Library”, “sub-Trillion Single Domain Antibody Library”, stable expressing cell line and small-scale process development platforms. Sanyou Bio has provided world-class innovative antibody drug research services including integrated antibody discovery and validation, staged technical service and PCC antibody license-out.
Up to July 2019, Sanyou Bio has served more than 70 domestic and international pharmaceutical and biotechnology companies, and more than 80% of the customers seek for further collaborations.

Fish & Richardson P.C

Fish & Richardson is the premier global intellectual property (IP) law firm. Established in 1878, and now with over 400 attorneys and technology specialists in the U.S., Europe, and China, Fish is trusted by the world’s most innovative companies to protect and enforce their IP assets.